Trump's FDA Pick: A Recipe for Regulatory Disaster? The recent nomination of Dr.
Heidi Overton to lead the FDA has sent shockwaves through the healthcare community, sparking concerns about the agency's future under her tenure.
As a White House policy aide with no experience in regulatory affairs, her appointment raises questions about the deliberate attempt to reshape the FDA.